Ryan Scott is a contributing writer for various publications, including SlashFilm, Texas A&M University-Commerce, FANGORIA, Newswav, and more. With a diverse range of interests, Ryan covers topics such as film, entertainment, technology, healthcare, and more, providing insightful and engaging articles for his readers.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Ryan Scott's coverage includes a mix of entertainment news and gaming, with a focus on box office performance, movie franchises, and industry trends. Pitches to Ryan should highlight insights into box office performances, movie franchises or gaming-related developments.
Given the prevalence of data citations in his articles, he would likely appreciate pitches supported by relevant statistics or research related to box office performance trends or audience preferences in movies and gaming.
As Ryan does not have a specific geographic focus but covers global entertainment news, pitches with an international perspective on box office successes and failures across different regions could be well-received.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The box office has been firmly in recovery mode for several years now. The pandemic, it's no secret, completely upended the business, and movie
From a South Korean horror film to one of the most acclaimed sequels in recent memory, we're counting down the biggest box office hits of 2024 so far.
By: Ryan Scott
Ryan Gosling and Emily Blunt are coming off Barbie and Oppenheimer, but can they work their magic on The Fall Guy's box office? Let's investigate.
It's no secret that the first third of 2024 has been at best uneven as far as the box office goes.
The actress says Blumhouse and Universal just need to get their ducks in a row.
By: Ryan Scott
Robert W. Mutter, MD, discusses personalized treatment approaches with radiation and endocrine therapy with
CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.
By: Ryan Scott
"Evil Dead" fans had to wait a full decade between movies following the release of Fede Álvarez's 2013 entry in the long-running horror franchise.
By: Ryan Scott
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
Survios is bringing Xenomorphs to VR just in time for the holiday season in 2024.
(833) 317-6278 
